Your browser doesn't support javascript.
loading
Characterization of potent and selective iodonium-class inhibitors of NADPH oxidases.
Lu, Jiamo; Risbood, Prabhakar; Kane, Charles T; Hossain, Md Tafazzal; Anderson, Larry; Hill, Kimberly; Monks, Anne; Wu, Yongzhong; Antony, Smitha; Juhasz, Agnes; Liu, Han; Jiang, Guojian; Harris, Erik; Roy, Krishnendu; Meitzler, Jennifer L; Konaté, Mariam; Doroshow, James H.
Afiliación
  • Lu J; Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
  • Risbood P; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Kane CT; Starks Associates Inc., Buffalo, NY 14213, USA.
  • Hossain MT; Starks Associates Inc., Buffalo, NY 14213, USA.
  • Anderson L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Hill K; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Monks A; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Wu Y; Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
  • Antony S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Juhasz A; Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
  • Liu H; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Jiang G; Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
  • Harris E; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Roy K; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Meitzler JL; Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
  • Konaté M; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA.
  • Doroshow JH; Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA. Electronic address: doroshoj@mail.nih.gov.
Biochem Pharmacol ; 143: 25-38, 2017 11 01.
Article en En | MEDLINE | ID: mdl-28709950
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos Onio / Tiofenos / Proliferación Celular / Inhibidores Enzimáticos / NADH NADPH Oxidorreductasas Límite: Humans Idioma: En Revista: Biochem Pharmacol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos Onio / Tiofenos / Proliferación Celular / Inhibidores Enzimáticos / NADH NADPH Oxidorreductasas Límite: Humans Idioma: En Revista: Biochem Pharmacol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos